Literature DB >> 18419383

Varicella outbreak epidemiology in an active surveillance site, 1995-2005.

Rachel Civen1, Adriana S Lopez, John Zhang, Jorge Garcia-Herrera, D Scott Schmid, Sandra S Chaves, Laurene Mascola.   

Abstract

We describe trends and characteristics of varicella outbreaks identified in an active surveillance site from 1995 to 2005. Cases of varicella were reported to the active surveillance project, and outbreaks were defined retrospectively as > or =5 varicella cases epidemiologically linked to a common setting that occurred within 1 incubation period. Outbreaks were grouped by calendar year. From 1995-1998 to 2002-2005, varicella outbreaks significantly decreased in number, from 236 to 46 (P< .001); in size, from a median of 15 cases/outbreak to 9 cases/outbreak (P< .001); and in duration, from 44.5 days to 30 days (P< .001). The median age of case patients with outbreak-related varicella increased from 6 to 9 years (P< .001). The 1-dose varicella vaccination program has been successful in decreasing the number of outbreaks and cases; however, challenges remain with regard to controlling outbreaks among vaccinated persons and targeting vaccination efforts to susceptible persons in older age groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419383     DOI: 10.1086/522144

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Lijun Zhai; Qingxiu Zheng; Xinghuo Pang; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

2.  Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Alexia Campbell; Shainoor Ismail; Ben Tan
Journal:  Can Commun Dis Rep       Date:  2010-10-18

3.  Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  Ben Tan; Shainoor Ismail
Journal:  Can Commun Dis Rep       Date:  2010-09-20

4.  Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Authors:  Dana Perella; Chengbin Wang; Rachel Civen; Kendra Viner; Karen Kuguru; Irini Daskalaki; D Scott Schmid; Adriana S Lopez; Hung Fu Tseng; E Claire Newbern; Laurene Mascola; Stephanie R Bialek
Journal:  Pediatrics       Date:  2016-03-14       Impact factor: 7.124

5.  Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Authors:  Stephanie R Bialek; Dana Perella; John Zhang; Laurene Mascola; Kendra Viner; Christina Jackson; Adriana S Lopez; Barbara Watson; Rachel Civen
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

6.  Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Authors:  Carrie A Thomas; Thein Shwe; Dee Bixler; Maria del Rosario; Scott Grytdal; Chengbin Wang; Loretta E Haddy; Stephanie R Bialek
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

7.  Single-dose varicella vaccine effectiveness in school settings in China.

Authors:  Zhe Wang; Huili Yang; Keli Li; Aihua Zhang; Zijian Feng; Jane F Seward; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2013-07-08       Impact factor: 3.641

8.  Varicella outbreak in a daycare: challenges and opportunities for preventing varicella outbreaks in this setting.

Authors:  Irini Daskalaki; Rodrerica Thermitus; Dana Perella; Kendra Viner; Niya Spells; Salini Mohanty; Adriana Lopez; Caroline Johnson
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

9.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

Review 10.  Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data.

Authors:  G S Goldman; P G King
Journal:  Vaccine       Date:  2012-06-01       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.